Babbette LaMarca
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Babbette LaMarca has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Kedra Wallace
Department of Pharmacology & Toxicology, University of Mississippi Medical Center, Jackson, MS 39216, USA
7 shared publications Gerd Wallukat
Experimental and Clinical Rsch Cntr, Charité Campus Buch, Max-Delbrück Cntr for Molecular Medicine, Berlin, Germany
6 shared publicationsJanae Moseley
5 shared publicationsMarc R. Parrish
5 shared publications- Florian Herse
Max-Delbrück-Center for Molecular Medicine in the Helmholtz Association (MDC), Berlin, Germany
4 shared publications James N. Martin
Department of Obstetrics and Gynecology, University of Mississippi Medical Center , Jackson , Mississippi, USA
4 shared publications
Latest Publications
- 1 September 2018
- Published by Wolters Kluwer Health in Hypertension
- Vol. 72 (Suppl_1)
Abstract P307: Renal Natural Killer Cell Activation and Mitochondrial Oxidative Stress; New Mechanisms in AT1-AA Mediated Hypertensive Pregnancy
Women with preeclampsia (PE) have increased blood pressure (MAP), natural killer (NK) cells, reactive oxygen species (ROS), and agonistic autoantibodies to the angiotensin II type 1 receptor (AT1-AA). AT1-AA’s administered to pregnant rodents produces a well-accepted model of PE. However, the role of NK cells and mitochondrial reactive oxygen species (mtROS) in AT1-AA mediated hypertension during pregnancy is unknown. We hypothesize that AT1-AA induced model of PE will exhibit elevated MAP, NK cells, and mtROS; while inhibition of the AT1-AA binding to the AT1R would be preventative. Pregnant rats were divided into 3 groups: normal pregnant (NP) (n=5), NP + AT1-AA infused (NP + AT1-AA) (n= 10), and NP + AT1-AA + AT1-AA inhibitory peptide (NP + AT1-AA + ‘n7AAc’) (n=8). Day 13, rats were surgically administered mini-pumps with either AT1-AA or AT1-AA+‘n7AAc’. Day 19, tissue and blood was collected. MAP was elevated in AT1-AA vs. NP (119±1 vs. 102±2 mmHg, pResearch Supported by NIH grants HL78147, HL51971, and HD067541 awarded to BL. DC is supported by NIH grant HL130456 and the American Heart Association 16SDG27520000.
- 1 September 2018
- Published by Wolters Kluwer Health in Hypertension
- Vol. 72 (Suppl_1)
Abstract P307: Renal Natural Killer Cell Activation and Mitochondrial Oxidative Stress; New Mechanisms in AT1-AA Mediated Hypertensive Pregnancy
Women with preeclampsia (PE) have increased blood pressure (MAP), natural killer (NK) cells, reactive oxygen species (ROS), and agonistic autoantibodies to the angiotensin II type 1 receptor (AT1-AA). AT1-AA’s administered to pregnant rodents produces a well-accepted model of PE. However, the role of NK cells and mitochondrial reactive oxygen species (mtROS) in AT1-AA mediated hypertension during pregnancy is unknown. We hypothesize that AT1-AA induced model of PE will exhibit elevated MAP, NK cells, and mtROS; while inhibition of the AT1-AA binding to the AT1R would be preventative. Pregnant rats were divided into 3 groups: normal pregnant (NP) (n=5), NP + AT1-AA infused (NP + AT1-AA) (n= 10), and NP + AT1-AA + AT1-AA inhibitory peptide (NP + AT1-AA + ‘n7AAc’) (n=8). Day 13, rats were surgically administered mini-pumps with either AT1-AA or AT1-AA+‘n7AAc’. Day 19, tissue and blood was collected. MAP was elevated in AT1-AA vs. NP (119±1 vs. 102±2 mmHg, pResearch Supported by NIH grants HL78147, HL51971, and HD067541 awarded to BL. DC is supported by NIH grant HL130456 and the American Heart Association 16SDG27520000.
- 1 January 2015
- Published by Elsevier in Pregnancy Hypertension
- Vol. 5 (1) , 28
[55-OR]
- 1 June 2012
- Published by Elsevier in Gender Medicine
- Vol. 9 (3) , 139-146
Agonistic Autoantibodies to the Angiotensin II Type I Receptor Cause Pathophysiologic Characteristics of Preeclampsia
- 1 June 2012
- Published by Elsevier in Gender Medicine
- Vol. 9 (3) , 139-146
Agonistic Autoantibodies to the Angiotensin II Type I Receptor Cause Pathophysiologic Characteristics of Preeclampsia
- 31 January 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (1) , S342
775: Posterior reversible encephalopathy syndrome (PRES) associated with eclampsia: the variable effects of therapeutic agents to accelerate safe recovery
- 31 January 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (1) , S342
775: Posterior reversible encephalopathy syndrome (PRES) associated with eclampsia: the variable effects of therapeutic agents to accelerate safe recovery
- 31 January 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (1) , S342
774: AT1-AA enhances renal sensitivity and blood pressure in response to ANGII during pregnancy
- 31 January 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (1) , S342
774: AT1-AA enhances renal sensitivity and blood pressure in response to ANGII during pregnancy
- 31 January 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (1) , S112
227: Blockade of CD4+ T cells prior to placental insult, attenuates hypertension in response to placental ischemia
- 31 January 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (1) , S112
227: Blockade of CD4+ T cells prior to placental insult, attenuates hypertension in response to placental ischemia
- 31 January 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (1) , S349
793: Placental oxidative stress is an important mediator of IL-17 induced hypertension during pregnancy
- 31 January 2012
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 206 (1) , S349
793: Placental oxidative stress is an important mediator of IL-17 induced hypertension during pregnancy
- Open Access
- 1 July 2011
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 24 (7) , 835-840
Hypertension in Response to AT1-AA: Role of Reactive Oxygen Species in Pregnancy-Induced Hypertension
Background. Agonistic autoantibodies to the angiotensin II type I receptor (AT1-AA) and reactive oxygen species (ROS) are implicated in the pathophysiology of
- 1 July 2011
- Published by Oxford University Press (OUP) in American Journal of Hypertension
- Vol. 24 (7) , 835-840
Open AccessHypertension in Response to AT1-AA: Role of Reactive Oxygen Species in Pregnancy-Induced Hypertension
Background. Agonistic autoantibodies to the angiotensin II type I receptor (AT1-AA) and reactive oxygen species (ROS) are implicated in the pathophysiology of
- 1 April 2011
- Published by Wolters Kluwer Health in Hypertension
- Vol. 57 (4) , 865-871
Hypertension in Response to Placental Ischemia During Pregnancy
Preeclampsia is associated with innate inflammatory response resulting in elevated tumor necrosis factor-α, agonistic autoantibodies to the angiotensin II type I receptor, and activation of endothelin 1 (ET-1). This study was designed to determine the role of B-cell depletion, resulting in agonistic autoantibodies to the angiotensin II type I receptor suppression to mediate hypertension via activation of ET-1 in the placental ischemic reduced uterine perfusion pressure (RUPP) rat model of preeclampsia. To achieve this goal we examined the effect of RUPP on mean arterial pressure and ET-1 in the presence and absence of chronically infused rituximab (R; 250 mg/kg), a B-lymphocyte–suppressive agent used clinically to treat autoimmune diseases. Mean arterial pressure was 103±1 mm Hg in normal pregnant (NP) rats; 103±3 mm Hg in NP+R versus 133±2 mm Hg in RUPP rats, and 118±2 mm Hg in RUPP+R rats ( P P <0.01) of RUPP+R versus RUPP rats. Media ET-1 excretion from endothelial cells exposed to serum from NP, RUPP, NP+R, or RUPP+R rats was determined. ET-1 from endothelial cells treated with NP serum was 53+13 pg/mg and increased to 75+10 pg/mg with RUPP serum. In contrast, ET-1 secretion decreased in response to B-cell–depleted RUPP serum to 50±8 pg/mg and was unchanged in response to NP+R sera (46±12 pg/mg). These data demonstrate the important roles that B-lymphocyte activation and agonistic autoantibodies to the angiotensin II type I receptors play in the pathophysiology of hypertension in response to placental ischemia.
- 1 April 2011
- Published by Wolters Kluwer Health in Hypertension
- Vol. 57 (4) , 865-871
Hypertension in Response to Placental Ischemia During Pregnancy
Preeclampsia is associated with innate inflammatory response resulting in elevated tumor necrosis factor-α, agonistic autoantibodies to the angiotensin II type I receptor, and activation of endothelin 1 (ET-1). This study was designed to determine the role of B-cell depletion, resulting in agonistic autoantibodies to the angiotensin II type I receptor suppression to mediate hypertension via activation of ET-1 in the placental ischemic reduced uterine perfusion pressure (RUPP) rat model of preeclampsia. To achieve this goal we examined the effect of RUPP on mean arterial pressure and ET-1 in the presence and absence of chronically infused rituximab (R; 250 mg/kg), a B-lymphocyte–suppressive agent used clinically to treat autoimmune diseases. Mean arterial pressure was 103±1 mm Hg in normal pregnant (NP) rats; 103±3 mm Hg in NP+R versus 133±2 mm Hg in RUPP rats, and 118±2 mm Hg in RUPP+R rats ( P P <0.01) of RUPP+R versus RUPP rats. Media ET-1 excretion from endothelial cells exposed to serum from NP, RUPP, NP+R, or RUPP+R rats was determined. ET-1 from endothelial cells treated with NP serum was 53+13 pg/mg and increased to 75+10 pg/mg with RUPP serum. In contrast, ET-1 secretion decreased in response to B-cell–depleted RUPP serum to 50±8 pg/mg and was unchanged in response to NP+R sera (46±12 pg/mg). These data demonstrate the important roles that B-lymphocyte activation and agonistic autoantibodies to the angiotensin II type I receptors play in the pathophysiology of hypertension in response to placental ischemia.